Why Canopy Growth Stock Keeps On Growing

10:52am, Wednesday, 06'th Sep 2023
Over the weekend, the White House threw its support behind legalizing medical marijuana. Yesterday, the Senate Majority Leader said he will push for marijuana banking reform.

Why Are Cannabis Stocks Still Up Today?

09:30am, Wednesday, 06'th Sep 2023
Stocks that deal in cannabis are rising as the U.S. government moves toward re-classifying marijuana. The Department of Health and Human Services (HHS) has asked the Drug Enforcement Administration (D
Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Huma
Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk
Canopy Growth Corporation's stock price rallied nearly 50% based on the news that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III. Other Canadian canna

Time to Get High on Pot Stocks? (3 Catalysts)

10:33am, Friday, 01'st Sep 2023
When it comes to marijuana, a significant disconnect exists between the US government and the American people. Stock Strategist Andrew Rocco explains why the worst may be over for marijuana investors.
Canopy Growth (CGC), Tilray (TLRY) and Cronos (CRON) shoot up on news that the DEA is considering recommendations for low-risk reclassification of marijuana.
If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.
The U.S. Department of Health and Human Services just recommended easing regulations on marijuana. The U.S. Drug Enforcement Agency may (or may not) take that advice.
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q
Cannabis stocks are up on Thursday as investors in the market react to news marijuana may be downgraded from a Schedule I drug. According to insiders, a member of the Department of Health and Human Se
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like
Canopy Growth issued 15.2 million common shares to Les Serres Stephane Bertrand as part of an amended agreement for the Canadian cannabis company to buy a 45% stake in Les Serres Vert Cannabis.

Why Canopy Growth Stock Was on Fire Today

05:16pm, Wednesday, 30'th Aug 2023
According to a media report, a top federal health official has formally requested the reclassification of marijuana. This indicates high-level government support for drug law reform, at least for cann
The Drug Enforcement Agency received an official recommendation to downgrade marijuana.  Currently, pot is classified as a Schedule I drug, on par with heroin.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE